Which has higher immunization, hib3, Oman or South Asia (IDA & IBRD)?

Oman, at 99.0% against 94.5% in South Asia (IDA & IBRD) as of 2024.

How many years of comparable data are there for Oman and South Asia (IDA & IBRD)?

23 years are reported by both, from 2002 to 2024.

Where does this data come from?

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Oman vs South Asia (IDA & IBRD): Immunization, Hib3

Oman

99.0%

in 2024

South Asia (IDA & IBRD)

94.5%

in 2024

Oman rank

1st

South Asia (IDA & IBRD) rank

1st

Immunization, Hib3 over time

Oman
South Asia (IDA & IBRD)

How they compare

Oman currently reports 99.0% against 94.5% in South Asia (IDA & IBRD), a difference of 4.5%.

Across all 23 years both countries report, Oman has been ahead every year.

Oman ranks 1st and South Asia (IDA & IBRD) ranks 1st of 191 countries.

Oman has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Oman	South Asia (IDA & IBRD)	Difference	Ahead
2000s	98.5%	1.4%	97.1%	Oman
2010s	98.8%	50.6%	48.2%	Oman
2020s	99.0%	90.6%	8.4%	Oman

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, hib3, Oman or South Asia (IDA & IBRD)?: Oman, at 99.0% against 94.5% in South Asia (IDA & IBRD) as of 2024.
What is the difference in immunization, hib3 between Oman and South Asia (IDA & IBRD)?: 4.5%, with Oman ahead.
How many years of comparable data are there for Oman and South Asia (IDA & IBRD)?: 23 years are reported by both, from 2002 to 2024.
How do Oman and South Asia (IDA & IBRD) rank globally for immunization, hib3?: Oman ranks 1st and South Asia (IDA & IBRD) ranks 1st of 191 countries.
Where does this data come from?: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Oman vs South Asia (IDA & IBRD): Immunization, Hib3. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 17 September 2026, from https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/oman/south-asia-ida-and-ibrd/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-hib3-percent-of-children-ages-12-23-months/oman/south-asia-ida-and-ibrd/">Oman vs South Asia (IDA & IBRD): Immunization, Hib3</a> — Statizoid

About this data

Indicator: Immunization, Hib3 (% of children ages 12-23 months)
Unit: % of children ages 12-23 months
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 234 places, 5,441 data points, 1990–2024
Last refreshed: 03 September 2026

Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.